Literature DB >> 21720866

A locus on chromosome 9 is associated with differential response of 129S1/SvImJ and FVB/NJ strains of mice to systemic LPS.

Ivana V Yang1, Holly R Rutledge, Jun Yang, Laura A Warg, Sergio D Sevilla, David A Schwartz.   

Abstract

Although polymorphisms in TLR receptors and downstream signaling molecules affect the innate immune response, these variants account for only a portion of the ability of the host to respond to microorganisms. To identify novel genes that regulate the host response to systemic lipopolysaccharide (LPS), we created an F2 intercross between susceptible (FVB/NJ) and resistant (129S1/SvImJ) strains, challenged F2 progeny with LPS via intraperitoneal injection, and phenotyped 605 animals for survival and another 500 mice for serum concentrations of IL-1β and IL-6. Genome-wide scans were performed on pools of susceptible and resistant mice for survival, IL-1β, and IL-6. This approach identified a locus on the telomeric end of the q arm of chromosome 9 (0-40 Mb) that was associated with the differences in morbidity and serum concentrations of IL-1β and IL-6 following systemic LPS in FVB/NJ and 129S1/SvImJ strains of mice. Fine mapping narrowed the locus to 3.7 Mb containing 11 known genes, among which are three inflammatory caspases. We studied expression of genes within the locus by quantitative RT-PCR and showed that Casp1 and Casp12 levels are unaffected by LPS in both strains, whereas Casp4 is highly induced by LPS in FVB/NJ but not in 129S1/SvImJ mice. In conclusion, our mapping results indicate that a 3.7-Mb region on chromosome 9 contains a gene that regulates differential response to LPS in 129S1/SvImJ and FVB/NJ strains of mice. Differences in the induction of Casp4 expression by LPS in the two strains suggest that Casp4 is the most likely candidate gene in this region.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21720866      PMCID: PMC4157901          DOI: 10.1007/s00335-011-9340-8

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  30 in total

1.  High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR.

Authors:  S Germer; M J Holland; R Higuchi
Journal:  Genome Res       Date:  2000-02       Impact factor: 9.043

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Genetic regulation of endotoxin-induced airway disease.

Authors:  Donald N Cook; Shuibang Wang; Yonghong Wang; Gabriel P Howles; Gregory S Whitehead; Katherine G Berman; Tony D Church; Bryan C Frank; Renee M Gaspard; Yan Yu; John Quackenbush; David A Schwartz
Journal:  Genomics       Date:  2004-06       Impact factor: 5.736

Review 4.  The inflammasomes.

Authors:  Kate Schroder; Jurg Tschopp
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

5.  Mapping lipopolysaccharide response loci in mice using recombinant inbred and congenic strains.

Authors:  L E Matesic; A De Maio; R H Reeves
Journal:  Genomics       Date:  1999-11-15       Impact factor: 5.736

6.  Genes other than TLR4 are involved in the response to inhaled LPS.

Authors:  E Lorenz; M Jones; C Wohlford-Lenane; N Meyer; K L Frees; N C Arbour; D A Schwartz
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-11       Impact factor: 5.464

7.  Quantitative trait loci modulate neutrophil infiltration in the liver during LPS-induced inflammation.

Authors:  L E Matesic; E L Niemitz; A De Maio; R H Reeves
Journal:  FASEB J       Date:  2000-11       Impact factor: 5.191

8.  Genetic analysis of complex traits in the emerging Collaborative Cross.

Authors:  David L Aylor; William Valdar; Wendy Foulds-Mathes; Ryan J Buus; Ricardo A Verdugo; Ralph S Baric; Martin T Ferris; Jeff A Frelinger; Mark Heise; Matt B Frieman; Lisa E Gralinski; Timothy A Bell; John D Didion; Kunjie Hua; Derrick L Nehrenberg; Christine L Powell; Jill Steigerwalt; Yuying Xie; Samir N P Kelada; Francis S Collins; Ivana V Yang; David A Schwartz; Lisa A Branstetter; Elissa J Chesler; Darla R Miller; Jason Spence; Eric Yi Liu; Leonard McMillan; Abhishek Sarkar; Jeremy Wang; Wei Wang; Qi Zhang; Karl W Broman; Ron Korstanje; Caroline Durrant; Richard Mott; Fuad A Iraqi; Daniel Pomp; David Threadgill; Fernando Pardo-Manuel de Villena; Gary A Churchill
Journal:  Genome Res       Date:  2011-03-15       Impact factor: 9.043

9.  Identification of genetic loci controlling bacterial clearance in experimental Salmonella enteritidis infection: an unexpected role of Nramp1 (Slc11a1) in the persistence of infection in mice.

Authors:  J Caron; J C Loredo-Osti; L Laroche; E Skamene; K Morgan; D Malo
Journal:  Genes Immun       Date:  2002-06       Impact factor: 2.676

10.  Caspase-11 gene expression in response to lipopolysaccharide and interferon-gamma requires nuclear factor-kappa B and signal transducer and activator of transcription (STAT) 1.

Authors:  Reinout Schauvliege; Jill Vanrobaeys; Peter Schotte; Rudi Beyaert
Journal:  J Biol Chem       Date:  2002-08-26       Impact factor: 5.157

View more
  3 in total

1.  Metabotropic glutamate receptor subtype 5 is altered in LPS-induced murine neuroinflammation model and in the brains of AD and ALS patients.

Authors:  Adrienne Müller Herde; Roger Schibli; Markus Weber; Simon M Ametamey
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-05       Impact factor: 9.236

2.  An inactivating caspase 11 passenger mutation originating from the 129 murine strain in mice targeted for c-IAP1.

Authors:  Niall S Kenneth; J Michael Younger; Elizabeth D Hughes; Danielle Marcotte; Philip A Barker; Thomas L Saunders; Colin S Duckett
Journal:  Biochem J       Date:  2012-04-15       Impact factor: 3.857

Review 3.  LPS-induced Murine Neuroinflammation Model: Main Features and Suitability for Pre-clinical Assessment of Nutraceuticals.

Authors:  Miryam Nava Catorce; Goar Gevorkian
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.